Forest Baskett - Net Worth and Insider Trading

Forest Baskett Net Worth

The estimated net worth of Forest Baskett is at least $5.5 Billion dollars as of 2025-01-12. Forest Baskett is the Director of Robinhood Markets Inc and owns about 47,664,751 shares of Robinhood Markets Inc (HOOD) stock worth over $1.9 Billion. Forest Baskett is the 10% Owner of Tesaro Inc and owns about 10,420,645 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Forest Baskett is also the Director, 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,603,013 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Besides these, Forest Baskett also holds Cloudflare Inc (NET) , Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Mirum Pharmaceuticals Inc (MIRM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Savara Inc (SVRA) , Adaptimmune Therapeutics PLC (ADAP) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , MBX Biosciences Inc (MBX) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Korro Bio Inc (KRRO) , Liquidia Corp (LQDA) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Epizyme Inc (EPZM) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Surface Oncology Inc (SURF) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , Metacrine Inc (MTCR) , TRACON Pharmaceuticals Inc (TCON) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) , Appian Corp (APPN) . Details can be seen in Forest Baskett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Forest Baskett has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Forest Baskett

Forest Baskett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Forest Baskett owns 95 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Mersana Therapeutics Inc (MRSN) among others .

Click here to see the complete history of Forest Baskett’s form 4 insider trades.

Insider Ownership Summary of Forest Baskett

Ticker	Comapny	Transaction Date	Type of Owner
EAR	Eargo Inc	2020-10-20	10 percent owner
MTCR	Metacrine Inc	2021-12-22	10 percent owner
MRSN	Mersana Therapeutics Inc	2020-04-13	10 percent owner
		2020-11-11	10 percent owner
		2019-12-12	10 percent owner
		2020-07-28	10 percent owner
		2022-05-25	10 percent owner
		2020-07-23	10 percent owner
		2020-07-09	10 percent owner
		2020-06-30	10 percent owner
		2020-06-19	10 percent owner
		2021-12-15	10 percent owner
		2018-04-23	10 percent owner
		2022-04-11	10 percent owner
		2020-04-02	10 percent owner
		2020-03-11	10 percent owner
		2015-03-11	10 percent owner
		2020-02-06	10 percent owner
		2020-01-29	10 percent owner
		2020-01-24	10 percent owner
		2020-12-04	10 percent owner
		2019-11-26	10 percent owner
		2019-11-06	10 percent owner
		2019-10-30	10 percent owner
		2019-07-22	10 percent owner
		2019-06-07	10 percent owner
		2019-01-22	10 percent owner
		2018-12-07	10 percent owner
		2018-10-17	10 percent owner
		2021-03-16	10 percent owner
		2018-10-04	10 percent owner
		2018-07-30	10 percent owner
		2018-05-01	10 percent owner
		2018-03-27	10 percent owner
		2018-03-09	10 percent owner
		2018-02-26	10 percent owner
		2018-02-26	10 percent owner
		2017-11-27	10 percent owner
		2015-09-30	10 percent owner
		2018-01-01	10 percent owner
		2017-11-20	10 percent owner
		2017-11-06	10 percent owner
		2017-10-10	10 percent owner
		2015-01-26	10 percent owner
		2016-12-19	10 percent owner
		2016-12-05	director
		2016-09-21	10 percent owner
		2016-07-29	10 percent owner
		2016-06-14	10 percent owner
		2016-02-03	10 percent owner
		2016-01-12	10 percent owner
		2015-06-17	10 percent owner
		2015-10-14	10 percent owner
		2015-01-22	10 percent owner
		2014-01-30	10 percent owner
		2014-11-25	10 percent owner
		2014-10-08	10 percent owner
		2014-08-27	10 percent owner
		2014-08-06	10 percent owner
		2014-04-02	10 percent owner
		2013-05-22	10 percent owner
		2014-01-09	10 percent owner
		2013-10-29	10 percent owner
		2013-08-15	10 percent owner
		2011-11-21	10 percent owner
		2012-10-11	10 percent owner
		2012-10-29	10 percent owner
		2012-03-28	10 percent owner
		2007-05-30	10 percent owner
		2009-10-01	10 percent owner
		2011-03-10	10 percent owner
		2009-04-03	10 percent owner
		2023-07-17	10 percent owner
		2016-02-10	10 percent owner
		2021-10-21	10 percent owner
		2018-12-07	10 percent owner
		2021-04-08	10 percent owner
		2021-03-30	10 percent owner
		2021-01-01	10 percent owner
		2021-06-24	10 percent owner
		2020-12-09	10 percent owner
		2022-01-31	director & 10 percent owner
		2022-12-22	10 percent owner
		2021-07-21	10 percent owner
		2021-09-30	10 percent owner
		2021-06-23	10 percent owner
		2021-12-03	10 percent owner
		2022-06-08	10 percent owner
		2022-08-03	10 percent owner
		2016-02-10	10 percent owner
		2020-03-11	10 percent owner
		2018-01-19	10 percent owner
		2023-07-13	10 percent owner
		2021-07-21	10 percent owner
		2024-04-22	10 percent owner

Forest Baskett Latest Holdings Summary

Forest Baskett currently owns a total of 40 stocks. Among these stocks, Forest Baskett owns 47,664,751 shares of Robinhood Markets Inc (HOOD) as of January 31, 2022, with a value of $1.9 Billion and a weighting of 34.91%. Forest Baskett owns 10,420,645 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 14.27%. Forest Baskett also owns 13,603,013 shares of iShares Indl/Office Real Estate Capped (FNIO) as of May 1, 2012, with a value of $434 Million and a weighting of 7.93%. The other 37 stocks Cloudflare Inc (NET) , Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Rhythm Pharmaceuticals Inc (RYTM) , Mirum Pharmaceuticals Inc (MIRM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Savara Inc (SVRA) , Adaptimmune Therapeutics PLC (ADAP) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , MBX Biosciences Inc (MBX) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Korro Bio Inc (KRRO) , Liquidia Corp (LQDA) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Epizyme Inc (EPZM) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Surface Oncology Inc (SURF) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , Metacrine Inc (MTCR) , TRACON Pharmaceuticals Inc (TCON) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Tableau Software Inc (DATA) , ARYx Therapeutics Inc (ARYX) , Appian Corp (APPN) have a combined weighting of 42.89% among all his current holdings.

Latest Holdings of Forest Baskett

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HOOD	Robinhood Markets Inc	2022-01-31	47,664,751	40.08	1,910,403,220
TSRO	Tesaro Inc	2018-03-06	10,420,645	74.96	781,131,549
FNIO	iShares Indl/Office Real Estate Capped	2012-05-01	13,603,013	31.89	433,800,085
NET	Cloudflare Inc	2020-11-11	3,842,216	112.62	432,710,366
ACLX	Arcellx Inc	2022-12-22	4,745,262	69.08	327,802,699
SUPN	Supernus Pharmaceuticals Inc	2015-06-17	7,641,250	37.49	286,470,463
RYTM	Rhythm Pharmaceuticals Inc	2017-10-10	4,909,956	56.17	275,792,229
MIRM	Mirum Pharmaceuticals Inc	2019-07-22	4,186,243	41.32	172,975,561
RARX	Ra Pharmaceuticals Inc	2016-10-31	3,490,073	47.99	167,488,603
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
SVRA	Savara Inc	2023-07-17	24,471,264	2.78	68,030,114
ADAP	Adaptimmune Therapeutics PLC	2020-01-24	102,478,668	0.62	63,536,774
AVEO	AVEO Pharmaceuticals Inc	2020-06-19	3,952,958	15.00	59,294,370
AKUS	Akouos Inc	2020-06-30	4,294,207	13.29	57,070,011
ARDX	Ardelyx Inc	2021-12-15	10,752,012	5.07	54,512,701
MBX	MBX Biosciences Inc	2024-09-16	3,614,486	13.69	49,482,313
GRPN	Groupon Inc	2013-08-15	3,709,248	12.16	45,104,456
TRVI	Trevi Therapeutics Inc	2022-04-11	10,421,428	3.82	39,809,855
KRRO	Korro Bio Inc	2024-04-22	1,090,793	35.26	38,461,361
LQDA	Liquidia Corp	2018-07-30	2,484,870	12.19	30,290,565
INWK	InnerWorkings Inc	2012-02-29	6,029,190	2.99	18,027,278
MM	Millennial Media Inc	2012-10-29	8,196,614	1.75	14,344,075
EPZM	Epizyme Inc	2016-01-12	6,260,851	1.47	9,203,451
MRSN	Mersana Therapeutics Inc	2020-04-13	7,962,710	0.72	5,733,151
INZY	Inozyme Pharma Inc	2020-07-28	2,437,689	2.00	4,863,190
SURF	Surface Oncology Inc	2018-04-23	3,312,877	1.07	3,544,778
MRKR	Marker Therapeutics Inc	2021-03-16	1,071,429	2.83	3,032,144
RGLS	Regulus Therapeutics Inc	2020-12-04	645,106	1.41	909,599
EAR	Eargo Inc	2020-10-20	326,001	2.57	837,823
DERM	Dermira Inc	2014-10-02	17,241	18.75	323,269
ILIU	Interleukin Genetics Inc	2016-07-29	55,418,811	0.00	249,385
AKAOQ	Achaogen Inc	2016-12-19	5,215,128	0.03	130,378
CLVSQ	Clovis Oncology Inc	2011-11-21	3,419,671	0.02	51,295
MTCR	Metacrine Inc	2021-12-22	2,563,257	0.00	3,589
TCON	TRACON Pharmaceuticals Inc	2018-03-27	17,330	0.03	558
ABIO	ARCA biopharma Inc	2018-02-26	0	25.50	0
GNCAQ	Genocea Biosciences Inc	2022-05-25	0	0.00	0
DATA	Tableau Software Inc	2016-12-05	0	169.53	0
ARYX	ARYx Therapeutics Inc	2011-03-10	0	0.00	0
APPN	Appian Corp	2017-11-27	0	33.68	0

Holding Weightings of Forest Baskett

Forest Baskett Form 4 Trading Tracker

According to the SEC Form 4 filings, Forest Baskett has made a total of 1 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Robinhood Markets Inc is the sale of 2,082 shares on January 31, 2022, which brought Forest Baskett around $29,606.

According to the SEC Form 4 filings, Forest Baskett has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Forest Baskett around $8 Million.

According to the SEC Form 4 filings, Forest Baskett has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 3,881 shares on May 1, 2012, which brought Forest Baskett around $99,975.

More details on Forest Baskett's insider transactions can be found in the Insider Trading History of Forest Baskett table.

Insider Trading History of Forest Baskett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Forest Baskett Trading Performance

GuruFocus tracks the stock performance after each of Forest Baskett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Forest Baskett is 7.94%. GuruFocus also compares Forest Baskett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Forest Baskett within 3 months outperforms 31 times out of 56 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Forest Baskett's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Forest Baskett

Average Return

Average return per transaction

Outperforming Transactions

13 out of 53 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.1
Relative Return to S&P 500(%)	5.08

Forest Baskett Ownership Network

Ownership Network List of Forest Baskett

No Data

Ownership Network Relation of Forest Baskett

Forest Baskett Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Forest Baskett is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 1,514 shares made by William Brownie , a net sale of 19 shares made by Adam Laponis , and a net sale of 3 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,536 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,536 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eargo Inc Insider Transactions

No Available Data

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Forest Baskett is the 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metacrine Inc Insider Transactions

No Available Data

What does Mersana Therapeutics Inc do?

Who are the key executives at Mersana Therapeutics Inc?

Forest Baskett is the 10 percent owner of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include SVP & Chief Development Officer Mohan Bala , Sr. VP & Finance & Product stgy Brian Deschuytner , and VP & Controller Ashish Mandelia .

Mersana Therapeutics Inc (MRSN) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 20,914 shares made by Mohan Bala , a net sale of 24,096 shares made by Timothy B Lowinger , and a net sale of 23,014 shares made by Brian Deschuytner .

In summary, during the past 3 months, insiders sold 1,884 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 1,884 shares. During the past 18 months, 184,420 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 184,420 shares.

Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mersana Therapeutics Inc Insider Transactions

No Available Data

What does Cloudflare Inc do?

Who are the key executives at Cloudflare Inc?

Forest Baskett is the 10 percent owner of Cloudflare Inc. Other key executives at Cloudflare Inc include director & 10 percent owner & CEO and Chair of the Board Matthew Prince , Chief Financial Officer Thomas J Seifert , and General Counsel Douglas James Kramer .

Cloudflare Inc (NET) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Cloudflare Inc (NET). Other recent insider transactions involving Cloudflare Inc (NET) include a net sale of 846,604 shares made by Carl Ledbetter , a net sale of 792,608 shares made by Thomas J Seifert , and a net sale of 2,828,736 shares made by Matthew Prince .

In summary, during the past 3 months, insiders sold 926,931 shares of Cloudflare Inc (NET) in total and bought 0 shares, with a net sale of 926,931 shares. During the past 18 months, 6,374,449 shares of Cloudflare Inc (NET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,374,449 shares.

Cloudflare Inc (NET)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cloudflare Inc Insider Transactions

No Available Data

What does Sprout Social Inc do?

Who are the key executives at Sprout Social Inc?

Forest Baskett is the 10 percent owner of Sprout Social Inc. Other key executives at Sprout Social Inc include CFO and Treasurer Preto Joseph Del , President Ryan Paul Barretto , and director & 10 percent owner & Chairman and CEO Justyn Russell Howard .

Sprout Social Inc (SPT) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Sprout Social Inc (SPT). Other recent insider transactions involving Sprout Social Inc (SPT) include a net sale of 41,926 shares made by Preto Joseph Del , a net sale of 523,595 shares made by Justyn Russell Howard , and a net sale of 194,329 shares made by Ryan Paul Barretto .

In summary, during the past 3 months, insiders sold 82,306 shares of Sprout Social Inc (SPT) in total and bought 0 shares, with a net sale of 82,306 shares. During the past 18 months, 981,071 shares of Sprout Social Inc (SPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 981,071 shares.

Sprout Social Inc (SPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sprout Social Inc Insider Transactions

No Available Data

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Forest Baskett is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , a net purchase of 833,333 shares made by Robert Lorne Hopfner , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inozyme Pharma Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Forest Baskett is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .

Genocea Biosciences Inc (GNCAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Forest Baskett is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Financial Officer Jennifer Lew , and EVP & Chief Business Officer Michael Overdorf .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 25,600 shares made by William H. Carson , and a net sale of 5,506 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 5,408 shares of Annexon Inc (ANNX) in total and bought 3,200 shares, with a net sale of 2,208 shares. During the past 18 months, 90,357 shares of Annexon Inc (ANNX) were sold and 375,600 shares were bought by its insiders, resulting in a net purchase of 285,243 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annexon Inc Insider Transactions

No Available Data

What does Nkarta Inc do?

Who are the key executives at Nkarta Inc?

Forest Baskett is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include Chief Legal Officer Alicia J. Hager , Chief Medical Officer David Shook , and Sr. VP & Technical Operations Ralph Brandenberger .

Nkarta Inc (NKTX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 9,159 shares made by James Trager , a net sale of 8,677 shares made by Alicia J. Hager , and a net sale of 5,339 shares made by David Shook .

In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,383 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,962,617 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nkarta Inc Insider Transactions

No Available Data

What does Akouos Inc do?

Who are the key executives at Akouos Inc?

Forest Baskett is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .

Akouos Inc (AKUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akouos Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Forest Baskett is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , Chief Development Officer David P. Rosenbaum , and Chief Medical Officer Laura A Williams .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 439,359 shares made by Michael Raab , a net sale of 304,930 shares made by David P. Rosenbaum , and a net sale of 495,440 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 237,529 shares of Ardelyx Inc (ARDX) in total and bought 429,168 shares, with a net purchase of 191,639 shares. During the past 18 months, 2,037,064 shares of Ardelyx Inc (ARDX) were sold and 429,168 shares were bought by its insiders, resulting in a net sale of 1,607,896 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Surface Oncology Inc do?

Who are the key executives at Surface Oncology Inc?

Forest Baskett is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .

Surface Oncology Inc (SURF) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Surface Oncology Inc (SURF). Other recent insider transactions involving Surface Oncology Inc (SURF) include a net sale of 16,713 shares made by Robert W. Ross , a net sale of 9,434 shares made by Jessica Fees , and a net sale of 7,042 shares made by Alison Oneill .

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,090 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,090 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surface Oncology Inc Insider Transactions

No Available Data

What does Trevi Therapeutics Inc do?

Who are the key executives at Trevi Therapeutics Inc?

Forest Baskett is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .

Trevi Therapeutics Inc (TRVI) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 90,795 shares made by Jennifer L Good , a net sale of 6,528 shares made by Lisa Delfini , and a net sale of 101,369 shares made by Thomas Sciascia .

In summary, during the past 3 months, insiders sold 0 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 203,247 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 203,247 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevi Therapeutics Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Scott D Sandell .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does Imara Inc do?

Who are the key executives at Imara Inc?

Forest Baskett is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .

Imara Inc (IMRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Imara Inc Insider Transactions

No Available Data

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Forest Baskett is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 75,504 shares made by Daniel Newman Mendelson ,

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 75,504 shares were bought by its insiders, resulting in a net purchase of 75,504 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Champions Oncology Inc Insider Transactions

No Available Data

What does Casper Sleep Inc do?

Who are the key executives at Casper Sleep Inc?

Forest Baskett is the 10 percent owner of Casper Sleep Inc. Other key executives at Casper Sleep Inc include Chief Financial Officer Michael P. Monahan , director & Chief Strategy Officer Neil Parikh , and CCO & President Emilie Arel .

Casper Sleep Inc (CSPR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Casper Sleep Inc (CSPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Casper Sleep Inc (CSPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Casper Sleep Inc (CSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Casper Sleep Inc Insider Transactions

No Available Data

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Forest Baskett is the 10 percent owner of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 400,000 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 221,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 400,000 shares were bought by its insiders, resulting in a net purchase of 178,400 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Forest Baskett is the 10 percent owner of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 70,989 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 195,829 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 195,829 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Forest Baskett is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Sr. VP & General Counsel Christopher Ray Aker , Chief Operating Officer Joseph P Hagan , and Chief Financial Officer Crispina Calsada .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 21,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regulus Therapeutics Inc Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Forest Baskett is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Galera Therapeutics Inc do?

Who are the key executives at Galera Therapeutics Inc?

Forest Baskett is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include director & President and CEO Mel Sorensen , Chief Commercial Officer Mark Bachleda , and Chief Financial Officer Chris Degnan .

Galera Therapeutics Inc (GRTX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , a net purchase of 7,644,932 shares made by Nancy T Chang , and a net sale of 67,015 shares made by Mel Sorensen .

In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 7,644,932 shares, with a net purchase of 7,644,932 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 11,357,741 shares were bought by its insiders, resulting in a net purchase of 11,290,726 shares.

Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Galera Therapeutics Inc Insider Transactions

No Available Data

What does Oyster Point Pharma Inc do?

Who are the key executives at Oyster Point Pharma Inc?

Forest Baskett is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and Chief Commercial Officer John Snisarenko .

Oyster Point Pharma Inc (OYST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oyster Point Pharma Inc Insider Transactions

No Available Data

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include Chief Operating Officer Peter Radovich , SVP & Global Controller Jolanda Howe , and director & President and CEO Christopher Peetz .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 10,847 shares made by Jolanda Howe , a net purchase of 162,308 shares made by Patrick J Heron , and a net sale of 9,499 shares made by Peter Radovich .

In summary, during the past 3 months, insiders sold 12,737 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 0 shares, with a net sale of 12,737 shares. During the past 18 months, 93,712 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 176,308 shares were bought by its insiders, resulting in a net purchase of 82,596 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Nightstar Therapeutics PLC do?

Who are the key executives at Nightstar Therapeutics PLC?

Forest Baskett is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Scott D Sandell , 10 percent owner Peter J Barris , and director & 10 percent owner David M Mott .

Nightstar Therapeutics PLC (NITE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nightstar Therapeutics PLC Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Forest Baskett is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Forest Baskett is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does PhaseBio Pharmaceuticals Inc do?

Who are the key executives at PhaseBio Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .

PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PhaseBio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Forest Baskett is the 10 percent owner of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include 10 percent owner New Enterprise Associates 16, L.p. , Interim CFO Eliot M Lurier , and 10 percent owner Scott D Sandell .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Marker Therapeutics Inc (MRKR). Other recent insider transactions involving Marker Therapeutics Inc (MRKR) include a net purchase of 554,250 shares made by New Enterprise Associates 16, L.p. , and a net purchase of 11,085 shares made by Steve Elms .

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 565,335 shares, with a net purchase of 565,335 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 565,335 shares were bought by its insiders, resulting in a net purchase of 565,335 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

What does Elastic NV do?

Who are the key executives at Elastic NV?

Forest Baskett is the 10 percent owner of Elastic NV. Other key executives at Elastic NV include Chief Executive Officer Ashutosh Kulkarni , Chief Financial Officer Janesh Moorjani , and Chief Product Officer Ken Exner .

Elastic NV (ESTC) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Elastic NV (ESTC). Other recent insider transactions involving Elastic NV (ESTC) include a net sale of 1,130,635 shares made by Shay Banon , a net sale of 126,316 shares made by Ashutosh Kulkarni , and a net sale of 55,850 shares made by Carolyn Herzog .

In summary, during the past 3 months, insiders sold 2,752,725 shares of Elastic NV (ESTC) in total and bought 0 shares, with a net sale of 2,752,725 shares. During the past 18 months, 4,673,032 shares of Elastic NV (ESTC) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 4,653,032 shares.

Elastic NV (ESTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elastic NV Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

Forest Baskett is the 10 percent owner of Liquidia Corp. Other key executives at Liquidia Corp include SVP & Commercial Scott Moomaw , Chief Financial Officer Michael Kaseta , and General Counsel Russell Schundler .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 13,758 shares made by Jason Adair , a net sale of 14,011 shares made by Scott Moomaw , and a net sale of 33,720 shares made by Rajeev Saggar .

In summary, during the past 3 months, insiders sold 26,053 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 26,053 shares. During the past 18 months, 309,661 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,713,730 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

What does MuleSoft Inc do?

Who are the key executives at MuleSoft Inc?

Forest Baskett is the 10 percent owner of MuleSoft Inc. Other key executives at MuleSoft Inc include 10 percent owner Scott D Sandell , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Patrick J Kerins .

MuleSoft Inc (MULE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MuleSoft Inc (MULE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MuleSoft Inc (MULE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MuleSoft Inc (MULE)'s detailed insider trading history can be found in Insider Trading Tracker table.

MuleSoft Inc Insider Transactions

No Available Data

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Forest Baskett is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea 15 Gp, Llc , 10 percent owner Jon Sakoda , and 10 percent owner Florence Anthony A. Jr. .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Forest Baskett is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Tintri Inc do?

Who are the key executives at Tintri Inc?

Forest Baskett is the 10 percent owner of Tintri Inc. Other key executives at Tintri Inc include director & Chairman & CEO Kenneth Klein , 10 percent owner Insight Venture Associates Viii, Ltd. , and 10 percent owner Insight Venture Associates Viii, L.p. .

Tintri Inc (TNTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tintri Inc (TNTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tintri Inc (TNTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tintri Inc (TNTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tintri Inc Insider Transactions

No Available Data

What does Appian Corp do?

Who are the key executives at Appian Corp?

Forest Baskett is the 10 percent owner of Appian Corp. Other key executives at Appian Corp include 10 percent owner Abdiel Qualified Master Fund Lp , director & 10 percent owner Biddle Albert G.w. Iii , and Chief Revenue Officer Christopher M Jones .

Appian Corp (APPN) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Appian Corp (APPN). Other recent insider transactions involving Appian Corp (APPN) include a net purchase of 57,584 shares made by Abdiel Qualified Master Fund Lp , a net sale of 30,000 shares made by Christopher Winters , and a net sale of 13,068 shares made by Mark Matheos .

In summary, during the past 3 months, insiders sold 700 shares of Appian Corp (APPN) in total and bought 0 shares, with a net sale of 700 shares. During the past 18 months, 4,279,918 shares of Appian Corp (APPN) were sold and 4,300,234 shares were bought by its insiders, resulting in a net purchase of 20,316 shares.

Appian Corp (APPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Appian Corp Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Forest Baskett is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 267 shares made by , and a net sale of 372 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 79 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 79 shares. During the past 18 months, 639 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 639 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Strongbridge Biopharma PLC do?

Who are the key executives at Strongbridge Biopharma PLC?

Forest Baskett is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .

Strongbridge Biopharma PLC (SBBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Strongbridge Biopharma PLC Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Scientific Officer Arthur Taveras , and Chief Operating Officer Mary Dibiase .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 614,040 shares made by Paula Ragan , a net sale of 159,766 shares made by Mary Dibiase , and a net sale of 541,511 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 63,794 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 63,794 shares. During the past 18 months, 1,626,394 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,601,394 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Care.com Inc do?

Who are the key executives at Care.com Inc?

Forest Baskett is the 10 percent owner of Care.com Inc. Other key executives at Care.com Inc include 10 percent owner Ac/interactivecorp , 10 percent owner Capitalg Gp Llc , and 10 percent owner Alphabet Inc. .

Care.com Inc (CRCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Care.com Inc (CRCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Care.com Inc (CRCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Care.com Inc (CRCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Care.com Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include EVP & Head of North America Jennifer Chien , Chief Technical Officer Joseph Shulman , and Chief Human Resources Officer Pamela J. Cramer .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 184,943 shares made by Joseph Shulman , a net sale of 145,755 shares made by Jennifer Chien , and a net sale of 85,162 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 89,517 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 89,517 shares. During the past 18 months, 672,183 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 672,183 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Forest Baskett is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include director & Chief Executive Officer Steven Lo , Chief Financial Officer Christine Matthews , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Forest Baskett is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Tableau Software Inc do?

Who are the key executives at Tableau Software Inc?

Forest Baskett is the director of Tableau Software Inc. Other key executives at Tableau Software Inc include EVP & GC & Secretary Keenan Michael Conder , EVP & Product Development Mark Thomas Nelson , and Executive VP & Sales Kelly Wright .

Tableau Software Inc (DATA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tableau Software Inc (DATA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tableau Software Inc (DATA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tableau Software Inc (DATA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tableau Software Inc Insider Transactions

No Available Data

What does Sorrento Tech Inc do?

Who are the key executives at Sorrento Tech Inc?

Forest Baskett is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Samuel D Isaly , and 10 percent owner Orbimed Advisors Llc .

Sorrento Tech Inc (ROKA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Tech Inc Insider Transactions

No Available Data

What does Interleukin Genetics Inc do?

Who are the key executives at Interleukin Genetics Inc?

Forest Baskett is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner New Enterprise Associates 14, L.p. , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .

Interleukin Genetics Inc (ILIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interleukin Genetics Inc Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

Forest Baskett is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Scott D Sandell , and 10 percent owner M James Barrett .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Forest Baskett is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Forest Baskett is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include Sr. VP of IP & CSO Padmanabh P. Bhatt , director & President & CEO Jack A. Khattar , and Sr VP & Quality & GMP Oper. & IT Frank Mottola .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 120,000 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 21,235 shares made by Tami Tillotson Martin .

In summary, during the past 3 months, insiders sold 330,917 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 330,917 shares. During the past 18 months, 477,246 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 477,246 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Forest Baskett is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 1,000 shares made by June Sherie Almenoff ,

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 1,000 shares, with a net purchase of 1,000 shares. During the past 18 months, 0 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Box Inc do?

Who are the key executives at Box Inc?

Forest Baskett is the 10 percent owner of Box Inc. Other key executives at Box Inc include VP Chief Acct Ofr & Controller Eli Berkovitch , director & 10 percent owner & President & COO Daniel J Levin , and director & 10 percent owner & Chief Financial Officer Dylan C Smith .

Box Inc (BOX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Box Inc (BOX). Other recent insider transactions involving Box Inc (BOX) include a net sale of 221,000 shares made by Dylan C Smith , a net sale of 60,000 shares made by Aaron Levie , and a net sale of 23,342 shares made by Eli Berkovitch .

In summary, during the past 3 months, insiders sold 249,730 shares of Box Inc (BOX) in total and bought 0 shares, with a net sale of 249,730 shares. During the past 18 months, 691,226 shares of Box Inc (BOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 691,226 shares.

Box Inc (BOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Box Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Forest Baskett is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Cvent Inc do?

Who are the key executives at Cvent Inc?

Forest Baskett is the 10 percent owner of Cvent Inc. Other key executives at Cvent Inc include Chief Financial Officer Cynthia A Russo , 10 percent owner Insight Venture Partners Vii, L.p. , and 10 percent owner Insight Venture Partners (delaware) Vii, L.p. .

Cvent Inc (CVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cvent Inc (CVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cvent Inc (CVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cvent Inc (CVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cvent Inc Insider Transactions

No Available Data

What does Dermira Inc do?

Who are the key executives at Dermira Inc?

Forest Baskett is the 10 percent owner of Dermira Inc. Other key executives at Dermira Inc include director & Chief Medical Officer Eugene A Bauer , director & CEO & Chairman of the Board Thomas G Wiggans , and CFO Andrew Guggenhime .

Dermira Inc (DERM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dermira Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Forest Baskett is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Aerohive Networks Inc do?

Who are the key executives at Aerohive Networks Inc?

Forest Baskett is the 10 percent owner of Aerohive Networks Inc. Other key executives at Aerohive Networks Inc include VP & Gen. Counsel & Secretary Stephen Debenham , SVP & CFO & COO John Ritchie , and 10 percent owner Lightspeed General Partner Vii, L.p. .

Aerohive Networks Inc (HIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerohive Networks Inc (HIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerohive Networks Inc (HIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerohive Networks Inc (HIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerohive Networks Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

Forest Baskett is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Forest Baskett is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 370,403 shares made by Edwin Rock , and a net purchase of 17,500 shares made by Brian M. Hahn .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,271,499 shares of GlycoMimetics Inc (GLYC) were sold and 387,903 shares were bought by its insiders, resulting in a net sale of 1,883,596 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does Xoom Corp do?

Who are the key executives at Xoom Corp?

Forest Baskett is the 10 percent owner of Xoom Corp. Other key executives at Xoom Corp include 10 percent owner Capital Xi Sequoia , 10 percent owner Sequoia Technology Partners Xi , and 10 percent owner Sequoia Capital Xi Principals Fund .

Xoom Corp (XOOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xoom Corp (XOOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xoom Corp (XOOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xoom Corp (XOOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xoom Corp Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Forest Baskett is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Forest Baskett is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Forest Baskett is the 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , EVP & General Counsel & Secty Richard Harry Sauer , and Co-President Sayan Chakraborty .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,670,529 shares made by David A Duffield , a net sale of 57,016 shares made by Richard Harry Sauer , and a net sale of 16,330 shares made by Douglas A. Robinson .

In summary, during the past 3 months, insiders sold 577,615 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 577,615 shares. During the past 18 months, 2,861,776 shares of Workday Inc (WDAY) were sold and 8,676 shares were bought by its insiders, resulting in a net sale of 2,853,100 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does Millennial Media Inc do?

Who are the key executives at Millennial Media Inc?

Forest Baskett is the 10 percent owner of Millennial Media Inc. Other key executives at Millennial Media Inc include VP & Controller & Treasurer Lara Sweet , director & President Robert Lord , and 10 percent owner Verizon Communications Inc .

Millennial Media Inc (MM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millennial Media Inc (MM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millennial Media Inc (MM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millennial Media Inc (MM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millennial Media Inc Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Forest Baskett is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Forest Baskett is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 208,562 shares made by Bradley L Campbell , a net sale of 309,059 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 22,901 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,901 shares. During the past 18 months, 755,405 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 755,405 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Forest Baskett is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Forest Baskett is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Forest Baskett is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 10,637 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,637 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 89,363 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Savara Inc do?

Who are the key executives at Savara Inc?

Forest Baskett is the 10 percent owner of Savara Inc. Other key executives at Savara Inc include Chief Financial Officer David L Lowrance , 10 percent owner Rick Yang , and 10 percent owner Scott D Sandell .

Savara Inc (SVRA) Insider Trades Summary

Over the past 18 months, Forest Baskett made 1 insider transaction in Savara Inc (SVRA) with a net purchase of 333,333. Other recent insider transactions involving Savara Inc (SVRA) include a net sale of 138,702 shares made by Matthew Pauls , a net sale of 35,000 shares made by David L Lowrance , and a net purchase of 333,333 shares made by Florence Anthony A. Jr. .

In summary, during the past 3 months, insiders sold 87,702 shares of Savara Inc (SVRA) in total and bought 120,000 shares, with a net purchase of 32,298 shares. During the past 18 months, 275,545 shares of Savara Inc (SVRA) were sold and 3,453,330 shares were bought by its insiders, resulting in a net purchase of 3,177,785 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Savara Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Forest Baskett is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Minerva Surgical Inc do?

Who are the key executives at Minerva Surgical Inc?

Forest Baskett is the 10 percent owner of Minerva Surgical Inc. Other key executives at Minerva Surgical Inc include 10 percent owner New Enterprise Associates 13 Lp , director & 10 percent owner Uri Geiger , and 10 percent owner Accelmed Partners Ii L.p. .

Minerva Surgical Inc (UTRS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Minerva Surgical Inc (UTRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Surgical Inc (UTRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Minerva Surgical Inc (UTRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Minerva Surgical Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Forest Baskett is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Forest Baskett is the 10 percent owner of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard , and a net sale of 15,625 shares made by Ashley Hall .

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,563 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 119,948 shares were bought by its insiders, resulting in a net purchase of 118,386 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

What does Coursera Inc do?

Who are the key executives at Coursera Inc?

Forest Baskett is the 10 percent owner of Coursera Inc. Other key executives at Coursera Inc include SVP & General Counsel Alan B Cardenas , See Remarks Richard J Jacquet , and director & See Remarks Jeffrey Nacey Maggioncalda .

Coursera Inc (COUR) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Coursera Inc (COUR). Other recent insider transactions involving Coursera Inc (COUR) include a net sale of 1,560,001 shares made by Jeffrey Nacey Maggioncalda , a net sale of 398,025 shares made by Shravan Goli , and a net sale of 843,582 shares made by Andrew Y. Ng .

In summary, during the past 3 months, insiders sold 33,664 shares of Coursera Inc (COUR) in total and bought 0 shares, with a net sale of 33,664 shares. During the past 18 months, 3,476,426 shares of Coursera Inc (COUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,476,426 shares.

Coursera Inc (COUR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Coursera Inc Insider Transactions

No Available Data

What does Verona Pharma PLC do?

Who are the key executives at Verona Pharma PLC?

Forest Baskett is the 10 percent owner of Verona Pharma PLC. Other key executives at Verona Pharma PLC include director & President and CEO David Zaccardelli , Chief Financial Officer Mark W Hahn , and Chief Medical Officer Kathleen A. Rickard .

Verona Pharma PLC (VRNA) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Verona Pharma PLC (VRNA). Other recent insider transactions involving Verona Pharma PLC (VRNA) include a net sale of 3,255,536 shares made by Mark W Hahn , a net sale of 3,255,536 shares made by David Zaccardelli , and a net sale of 484,856 shares made by Kathleen A. Rickard .

In summary, during the past 3 months, insiders sold 3,840,000 shares of Verona Pharma PLC (VRNA) in total and bought 101,240 shares, with a net sale of 3,738,760 shares. During the past 18 months, 7,075,952 shares of Verona Pharma PLC (VRNA) were sold and 330,976 shares were bought by its insiders, resulting in a net sale of 6,744,976 shares.

Verona Pharma PLC (VRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verona Pharma PLC Insider Transactions

No Available Data

What does NeueHealth Inc do?

Who are the key executives at NeueHealth Inc?

Forest Baskett is the 10 percent owner of NeueHealth Inc. Other key executives at NeueHealth Inc include Chief Financial Officer Jay Matushak , director & CEO and President Mikan George Lawrence Iii , and GC & CORPORATE SECRETARY Jeff Michael Craig .

NeueHealth Inc (NEUE) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 8,464 shares made by Jay Matushak , a net sale of 105,340 shares made by Mikan George Lawrence Iii , and a net sale of 2,804 shares made by Jeffrey J Scherman .

In summary, during the past 3 months, insiders sold 58,658 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 58,658 shares. During the past 18 months, 124,408 shares of NeueHealth Inc (NEUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 124,408 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeueHealth Inc Insider Transactions

No Available Data

What does Desktop Metal Inc do?

Who are the key executives at Desktop Metal Inc?

Forest Baskett is the 10 percent owner of Desktop Metal Inc. Other key executives at Desktop Metal Inc include CHIEF OPERATING OFFICER Thomas Nogueira , CFO & TREASURER Jason M Cole , and Chief Technology Officer Jonah Myerberg .

Desktop Metal Inc (DM) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Desktop Metal Inc (DM). Other recent insider transactions involving Desktop Metal Inc (DM) include a net sale of 384,064 shares made by Jason M Cole , a net sale of 190,004 shares made by Jonah Myerberg , and a net sale of 7,298 shares made by Thomas Nogueira .

In summary, during the past 3 months, insiders sold 0 shares of Desktop Metal Inc (DM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 86,362 shares of Desktop Metal Inc (DM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,362 shares.

Desktop Metal Inc (DM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Desktop Metal Inc Insider Transactions

No Available Data

What does Robinhood Markets Inc do?

Who are the key executives at Robinhood Markets Inc?

Forest Baskett is the director & 10 percent owner of Robinhood Markets Inc. Other key executives at Robinhood Markets Inc include Chief Legal Officer Gallagher Daniel Martin Jr , director & 10 percent owner & Chief Creative Officer Baiju Bhatt , and Chief Financial Officer Jason Warnick .

Robinhood Markets Inc (HOOD) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Robinhood Markets Inc (HOOD). Other recent insider transactions involving Robinhood Markets Inc (HOOD) include a net sale of 3,399,893 shares made by Baiju Bhatt , a net sale of 4,437,401 shares made by Vladimir Tenev , and a net sale of 722,851 shares made by Gallagher Daniel Martin Jr .

In summary, during the past 3 months, insiders sold 8,838,208 shares of Robinhood Markets Inc (HOOD) in total and bought 0 shares, with a net sale of 8,838,208 shares. During the past 18 months, 22,811,163 shares of Robinhood Markets Inc (HOOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,811,163 shares.

Robinhood Markets Inc (HOOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Robinhood Markets Inc Insider Transactions

No Available Data

What does Arcellx Inc do?

Who are the key executives at Arcellx Inc?

Forest Baskett is the 10 percent owner of Arcellx Inc. Other key executives at Arcellx Inc include Chief Financial Officer Michelle Gilson , director & See Remarks Rami Elghandour , and Chief Medical Officer Christopher Heery .

Arcellx Inc (ACLX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 366,507 shares made by Christopher Heery , a net sale of 80,979 shares made by Kavita Patel , and a net sale of 109,308 shares made by Michelle Gilson .

In summary, during the past 3 months, insiders sold 233,074 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 233,074 shares. During the past 18 months, 1,763,113 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,763,113 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcellx Inc Insider Transactions

No Available Data

What does Berkshire Grey Inc do?

Who are the key executives at Berkshire Grey Inc?

Forest Baskett is the 10 percent owner of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .

Berkshire Grey Inc (BGRY) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Berkshire Grey Inc (BGRY). Other recent insider transactions involving Berkshire Grey Inc (BGRY) include a net sale of 65,567,317 shares made by Svf Ii Bg (de) Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 65,567,317 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,567,317 shares.

Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Berkshire Grey Inc Insider Transactions

No Available Data

What does IonQ Inc do?

Who are the key executives at IonQ Inc?

Forest Baskett is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and Chief Financial Officer Thomas G. Kramer .

IonQ Inc (IONQ) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 226,985 shares made by Rima Alameddine , a net sale of 75,967 shares made by Thomas G. Kramer , and a net sale of 122,474 shares made by Peter Hume Chapman .

In summary, during the past 3 months, insiders sold 110,223 shares of IonQ Inc (IONQ) in total and bought 0 shares, with a net sale of 110,223 shares. During the past 18 months, 460,198 shares of IonQ Inc (IONQ) were sold and 115,005 shares were bought by its insiders, resulting in a net sale of 345,193 shares.

IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IonQ Inc Insider Transactions

No Available Data

What does Monte Rosa Therapeutics Inc do?

Who are the key executives at Monte Rosa Therapeutics Inc?

Forest Baskett is the 10 percent owner of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , Principal Accounting Officer Edmund Dunn , and General Counsel Philip Nickson .

Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , and a net sale of 2,817 shares made by Edmund Dunn .

In summary, during the past 3 months, insiders sold 157,895 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 157,895 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,860,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Monte Rosa Therapeutics Inc Insider Transactions

No Available Data

What does BuzzFeed Inc do?

Who are the key executives at BuzzFeed Inc?

Forest Baskett is the 10 percent owner of BuzzFeed Inc. Other key executives at BuzzFeed Inc include other: Member of 10% Group Johnson John S. Iii , 10 percent owner Comcast Corp , and CFO Matthew Omer .

BuzzFeed Inc (BZFD) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in BuzzFeed Inc (BZFD). Other recent insider transactions involving BuzzFeed Inc (BZFD) include a net sale of 874,174 shares made by Johnson John S. Iii , a net sale of 3,176,923 shares made by Comcast Corp , and a net sale of 30,801 shares made by Janet L Rolle .

In summary, during the past 3 months, insiders sold 30,801 shares of BuzzFeed Inc (BZFD) in total and bought 0 shares, with a net sale of 30,801 shares. During the past 18 months, 3,504,268 shares of BuzzFeed Inc (BZFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,504,268 shares.

BuzzFeed Inc (BZFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

BuzzFeed Inc Insider Transactions

No Available Data

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

Forest Baskett is the 10 percent owner of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include Chief Medical & Devt. Officer Kanya Rajangam , Chief Operating Officer Herberts Curt A. Iii , and 10 percent owner Bayer Us Holding Lp .

Senti Biosciences Inc (SNTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senti Biosciences Inc Insider Transactions

No Available Data

What does ZeroFox Holdings Inc do?

Who are the key executives at ZeroFox Holdings Inc?

Forest Baskett is the 10 percent owner of ZeroFox Holdings Inc. Other key executives at ZeroFox Holdings Inc include director & See Remarks James Christopher Foster , Chief Marketing Officer Prestridge Iii John R , and Chief Technology Officer Michael Morgan Price .

ZeroFox Holdings Inc (ZFOX) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in ZeroFox Holdings Inc (ZFOX). Other recent insider transactions involving ZeroFox Holdings Inc (ZFOX) include a net sale of 224,517 shares made by James Christopher Foster , a net sale of 59,691 shares made by Timothy S Bender , and a net sale of 54,174 shares made by Michael Morgan Price .

In summary, during the past 3 months, insiders sold 0 shares of ZeroFox Holdings Inc (ZFOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 515,540 shares of ZeroFox Holdings Inc (ZFOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 515,540 shares.

ZeroFox Holdings Inc (ZFOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ZeroFox Holdings Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Forest Baskett is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 7,250 shares made by Raymond J. Bartoszek , a net purchase of 15,000 shares made by Shawn Iadonato , and a net purchase of 6,500 shares made by Craig W. Philips .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 45,250 shares were bought by its insiders, resulting in a net purchase of 45,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

What does Enliven Therapeutics Inc do?

Who are the key executives at Enliven Therapeutics Inc?

Forest Baskett is the 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include Chief Operating Officer Anish Patel , Chief Financial Officer Benjamin Hohl , and director & President and CEO Samuel Kintz .

Enliven Therapeutics Inc (ELVN) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 98,814 shares made by Benjamin Hohl , a net sale of 240,342 shares made by Samuel Kintz , and a net sale of 239,847 shares made by Joseph P Lyssikatos .

In summary, during the past 3 months, insiders sold 52,074 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 52,074 shares. During the past 18 months, 4,894,576 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,894,576 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enliven Therapeutics Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Forest Baskett is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , EVP PHARM SCI & MFG Stapleton Raymond D Jr , and 10 percent owner Paul Edward Walker .

Genocea Biosciences Inc (GGNNQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Sagimet Biosciences Inc do?

Who are the key executives at Sagimet Biosciences Inc?

Forest Baskett is the 10 percent owner of Sagimet Biosciences Inc. Other key executives at Sagimet Biosciences Inc include General Counsel and CCO Elizabeth Rozek , director & President & CEO David Happel , and 10 percent owner New Enterprise Associates 13 Lp .

Sagimet Biosciences Inc (SGMT) Insider Trades Summary

Over the past 18 months, Forest Baskett made no insider transaction in Sagimet Biosciences Inc (SGMT). Other recent insider transactions involving Sagimet Biosciences Inc (SGMT) include a net purchase of 14,290 shares made by David Happel , a net sale of 37,687 shares made by George Kemble , and a net purchase of 29,338 shares made by New Enterprise Associates 13 Lp .

In summary, during the past 3 months, insiders sold 0 shares of Sagimet Biosciences Inc (SGMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 57,620 shares of Sagimet Biosciences Inc (SGMT) were sold and 91,165 shares were bought by its insiders, resulting in a net purchase of 33,545 shares.

Sagimet Biosciences Inc (SGMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sagimet Biosciences Inc Insider Transactions

No Available Data

What does Revolution Acceleration Acquisition Corp do?

Who are the key executives at Revolution Acceleration Acquisition Corp?

Forest Baskett is the 10 percent owner of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .

Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Acceleration Acquisition Corp Insider Transactions

No Available Data

What does Korro Bio Inc do?

Who are the key executives at Korro Bio Inc?

Forest Baskett is the 10 percent owner of Korro Bio Inc. Other key executives at Korro Bio Inc include Chief Financial Officer Vineet Agarwal , 10 percent owner Scott D Sandell , and 10 percent owner New Enterprise Associates 17, L.p. .

Korro Bio Inc (KRRO) Insider Trades Summary

Over the past 18 months, Forest Baskett made 1 insider transaction in Korro Bio Inc (KRRO) with a net purchase of 17,857. Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 11,016 shares made by Vineet Agarwal , a net sale of 2,124 shares made by David L. Lucchino , and a net purchase of 17,857 shares made by Mohamad Makhzoumi .

In summary, during the past 3 months, insiders sold 11,016 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 11,016 shares. During the past 18 months, 13,140 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 165,430 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Korro Bio Inc Insider Transactions

No Available Data

Forest Baskett Mailing Address

Above is the net worth, insider trading, and ownership report for Forest Baskett. Currently GuruFocus does not have mailing address information for Forest Baskett.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.